Psoriasis

Experts from the American Academy of Dermatology and the National Psoriasis Foundation teamed up to offer an extensive set of guidelines for the management of psoriasis.

Psoriatic arthritis is often a painful comorbidity for patients with psoriasis — and an expensive one at that. A 2016 study published in Actas Dermo-Sifiliográficas found the disease comes with a price tag to the tune of US$15,000 per patient in Europe. However, that price is also based on biologic drug use that can be as much as 80% cheaper than those in the United States or Canada.

MIAMI BEACH, Fla. — Anti-interleukin-23 agents tildrakizumab, guselkumab, risankizumab and mirikizumab are effective in treating patients with psoriasis, with one of the longest remission durations of any drug currently in use, according to a presenter at South Beach Symposium.

MIAMI BEACH, Fla. — JAK inhibitors are being studied to treat patients with psoriasis and atopic dermatitis, with many showing promising outcomes, according to a presenter at South Beach Symposium.

Statin use was associated with improvement in Psoriasis Area and Severity Index score among patients with severe psoriasis, according to a recently published meta-analysis.

Patients with psoriasis carry a slightly increased risk for cancer, particularly keratinocyte cancer and lymphomas, according to data published in JAMA Dermatology.

MIAMI BEACH, Fla. — Despite the plethora of biologics for psoriasis, the vehicle of treatment matters and topical therapies are here to stay, according to a speaker at South Beach Symposium.

MAUI, Hawaii — A novel TYK2 inhibitor may provide clinicians with another treatment option along the janus kinase pathway in patients with severe psoriasis, according to a presentation at the 2020 Rheumatology Winter Clinical Symposium.

Several novel treatments for moderate to severe plaque psoriasis were associated with the highest Psoriasis Area and Severity Index response rates, according to a comprehensive assessment of efficacy published in JAMA Dermatology.

MIAMI BEACH, Fla. — Here at the South Beach Symposium, meeting chair Mark S. Nestor, MD, PhD, reviewed current and future treatment options for psoriasis.